Evidence map›Paper›PMID 36632250›Full record

ReviewCureus2022

Increased Risk of Cardiovascular Diseases in Rheumatoid Arthritis: A Systematic Review.

Hadi Farhat, Huma Irfan, Kanmani Muthiah, Namratha Pallipamu, Sogand Taheri, Suvedha S Thiagaraj, Twisha S Shukla, Sai Dheeraj Gutlapalli, Sheiniz Giva, Sai Sri Penumetcha

Registry-linked trialAbstract readReview
In one paragraph

Review in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07772466 (Atherogenic Index of Plasma and Carotid Intima-media Thickness as Predictors of Preclinical Atherosclerosis in Early Rheumatoid Arthritis Patients Younger Than 50 Years of Age), which is not on this map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07772466 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Atherogenic Index of Plasma and Carotid Intima-media Thickness as Predictors of Preclinical Atherosclerosis in Early Rheumatoid Arthritis Patients Younger Than 50 Years of Age

TypeobservationalSponsorAssiut UniversityRan2026 to 2028Enrolled70ConditionsAtheroscleroses, Rheumatoid Arthritis (RA
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hadi FarhatCardiology and Rheumatology, University of Balamand, Beirut, LBN.
Huma IrfanResearch, Larkin Community Hospital, South Miami, USA.
Kanmani MuthiahNeurology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Namratha PallipamuInternal Medicine, Franciscan Health, Lafayette, USA.
Sogand TaheriMedical Science, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Suvedha S ThiagarajInternal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Twisha S ShuklaPediatrics, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Sai Dheeraj GutlapalliInternal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Sheiniz GivaNeonatology, Children's Health Ireland at Temple Street, Dublin, IRL.
Sai Sri PenumetchaGeneral Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is an autoimmune condition in which the body's joints are attacked by the immune system, leaving the patient disabled in severe cases, with irreversible joint damage and a lower quality of life. RA patients are more likely to develop cardiovascular (CV) disease, which increases their risk of morbidity and mortality. This study systematically reviews various CV diseases that might occur with RA including heart failure (HF), coronary artery disease, acute coronary syndrome, ischemic heart disease, stroke, cardiac death, venous thromboembolism, and valvular diseases. The relation between these complications and RA is specifically assessed. Systematic search was carried out on literature reporting the risk of each of the CV diseases in RA patients from databases in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The databases searched were MEDLINE (through PubMed) and Google Scholar using a combination of keywords and medical subject headings (MeSH). Our keywords were mainly "cardiovascular diseases" and "arthritis and rheumatoid". We found a total of 33 articles reporting each CV comorbidity. Interestingly, a wide spectrum of CV diseases is reported in patients with RA. Many tools were implemented in the diagnosis of each disease such as carotid intima-media thickness for atherosclerosis and echocardiography for HF. We confirmed that RA is associated with an increased risk of different CV events, and prophylactic measures should be implemented.

Indexed as

aortic stenosisatherosclerosiscardiac deathcardiovascular diseaseheart failureischemic heart diseasemyocardial infarctionrheumatoid arthriitisstrokevenous thromboembolism

Identifiers

PMID36632250
PMCPMC9827945

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.